Akebia Therapeutics AKBA
NASDAQ AKBA
$0.85 -0.02 (-1.85%)
As of: Oct 2, 2026 · 3:20 PM EDT

Akebia Therapeutics (AKBA) Depreciation & Amortization - Total (2019 - 2026)

Updated

Akebia Therapeutics (AKBA) reported Depreciation & Amortization - Total of $585,000 for Q2 2026, up 85.1% from $316,000 a year earlier and up 78.4% from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) Depreciation & Amortization - Total (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Akebia Therapeutics' Depreciation & Amortization - Total came in at $1.55 million, up 16.9% year-over-year; for FY2025, it was $1.27 million, down 13.2% from FY2024.

  • Depreciation & Amortization - Total has declined for six consecutive years, with a five-year compound annual growth rate of -9.6% (FY2020 to FY2025).
  • By year, Depreciation & Amortization - Total came in at $1.46 million in FY2024 (-7.8%), $1.59 million in FY2023 (-4.2%), $1.65 million in FY2022 (-12.9%) and $1.9 million in FY2021 (-9.5%).
  • The Q2 2026 figure ranks as the highest quarterly Depreciation & Amortization - Total since Q3 2019.
  • Year over year, Depreciation & Amortization - Total gained in two of the last eight quarters, with growth averaging 1.9%.
  • The high point for year-over-year Depreciation & Amortization - Total in five years was Q2 2026 (growth of 85.1%); the low point was Q2 2025 (a decline of 21.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $328,000 (Q1 2026), $321,000 (Q4 2025) and $318,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Akebia Therapeutics 250.00 Mn -419.48 Mn 38.70 Mn 585,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 585,000.00
Mar 31, 2026 328,000.00
Dec 31, 2025 321,000.00
Sep 30, 2025 318,000.00
Jun 30, 2025 316,000.00
Mar 31, 2025 314,000.00
Dec 31, 2024 335,000.00
Sep 30, 2024 363,000.00
Jun 30, 2024 400,000.00
Mar 31, 2024 364,000.00
Dec 31, 2023 394,000.00
Sep 30, 2023 396,000.00
Jun 30, 2023 397,000.00
Mar 31, 2023 398,000.00
Dec 31, 2022 408,000.00
Dec 31, 2020 500,000.00
Sep 30, 2020 500,000.00
Jun 30, 2020 500,000.00
Dec 31, 2019 500,000.00
Sep 30, 2019 600,000.00
API Access

Akebia Therapeutics Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=AKBA&period=max&api_key=YOUR_API_KEY